Molly Buckland, DO
MOHS-Micrographic Surgery · Bozeman, MTNPI 1811345093
Payments from drug & device makers
Across 241 payments — averaging $19.94 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- AbbVie$2K
- Novartis$428
- Lilly USA, LLC$399
- Amgen$329
- Sun Pharmaceutical Industries Inc.$283
- E.r. Squibb & Sons, L.L.C.$254
- plus $2K from 18 others
What the payments were for
- Food & beverage$4,68798%
- Education$1182%
Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| AbbVie(2 entities) | 96 | $1,535 |
| Novartis | 18 | $428 |
| Lilly USA, LLC | 25 | $399 |
| Amgen | 19 | $329 |
| Sun Pharmaceutical Industries Inc. | 7 | $283 |
| E.r. Squibb & Sons, L.L.C. | 11 | $254 |
| LEO Pharma Inc. | 5 | $239 |
| Sanofi | 7 | $158 |
| Merz North America, Inc. | 2 | $157 |
| Regeneron Healthcare Solutions, Inc. | 7 | $155 |
| Johnson & Johnson | 8 | $151 |
| Ortho Dermatologics, A Division Of Bausch Health US, LLC | 2 | $117 |
| UCB, Inc. | 5 | $113 |
| Kyowa Kirin, Inc. | 6 | $99 |
| Boehringer Ingelheim | 5 | $89 |
| Galderma Laboratories, L.p. | 4 | $70 |
| Pfizer | 4 | $68 |
| Incyte Corporation | 4 | $62 |
| Sanofi-aventis U.S. LLC | 1 | $23 |
| VYNE Pharmaceuticals Inc. | 1 | $23 |
| Mayne Pharma Commercial LLC | 1 | $17 |
| Arcutis Biotherapeutics, Inc. | 1 | $14 |
| Genentech USA, Inc. | 1 | $13 |
| Biofrontera Inc. | 1 | $10 |
What the payments were tied to
Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.
How this compares
Too few mohs-micrographic surgery providers in Montanato place this figure against a meaningful peer group, so we don't.
Medicare billing
What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| Taltz AutoinjectorIxekizumab | 12 | $82,395 |
| Fluorouracil | 38 | $3,175 |
| Doxycycline Hyclate | 37 | $2,932 |
| Tacrolimus | 17 | $1,345 |
| Ketoconazole | 66 | $1,243 |
| Metronidazole | 11 | $1,050 |
| Triamcinolone Acetonide | 127 | $1,008 |
| Clobetasol Propionate | 36 | $971 |
| Cephalexin | 144 | $559 |
| ValacyclovirValacyclovir Hcl | 28 | $502 |
| Doxycycline Monohydrate | 25 | $341 |
| Hydroxyzine Hcl | 25 | $223 |
| Fluconazole | 15 | $120 |
| Hydrocortisone | 17 | $109 |
| Minoxidil | 20 | $98 |
Paid to pharmacies, not to this prescriber.
Other mohs-micrographic surgery in Bozeman
- Kristen TownleyMissoula$4K
- Emilie JacobsenGreat Falls$1K
- Jonathan BinghamGreat Falls$439
- Logan SkelleyHelena$331
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Billing: Medicare Physician & Other Practitioners, data year 2024. Original Medicare Part B only.
- Identity: NPPES NPI Registry, July 2026.